Status of Valsartan Recall Claims to be Reviewed at Case Management Conference
A status conference on Wednesday will discuss how to move valsartan litigation forward with short form complaints and plaintiffs fact sheets.…
«
»
A status conference on Wednesday will discuss how to move valsartan litigation forward with short form complaints and plaintiffs fact sheets.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
The attorney overseeing all valsartan recall lawsuits has appointed attorneys to various leadership roles in the consolidated litigation over tainted generic blood pressure medications.…
Thousands of valsartan lawsuits may be filed over the coming two years as the recalls expand and more plaintiffs link their cancer cases to use of the tainted drugs.…
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.…
Plaintiffs can now file valsartan recall lawsuits over cancer injuries directly with the MDL court in New Jersey…
The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.…
The initial status conference for federal valsartan recall litigation is scheduled for March 27.…
A new editorial looks at the massive number of valsartan recalls as a stress test of the U.S. drug supply chain and call for the FDA and pharmacies to learn from the experience.…
The FDA has fast-tracked approval of a new generic valsartan tablet in the face of shortages due to recalls over cancer-causing impurities.…